Anuh Pharma Sept 2026 results: net profit up 47%, margins improve

Revenue declinedEBITDA margin expansionResults View source PDF Explain this filing

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.0%Reaction day

₹87.60

prior close

₹87.60

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.4%-5.4% vs market

Pharmaceuticals peers, median of 174sector+0.2%-4.2% vs sector

On the reaction day the stock moved 5.4 pts less than Nifty Microcap 250 and 4.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.9

10m

-4.0

15m

-5.3

30m

-2.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.0+1.4-5.4+0.2-4.2

Next day

-7.3+1.7-9.0+0.6-7.9

-5.3+3.9-9.2+1.6-6.9

-5.6+5.1-10.7+2.3-7.9

-6.5pendingpending+2.3-8.8

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anuh Pharma's Sept 2026 results were unaudited, with limited review. For Q3, revenue fell 0.3% year on year to Rs 18,524.14 lakh while net profit rose 47% to Rs 1,121.31 lakh. Half-year revenue rose 2% year on year to Rs 37,905.18 lakh and net profit rose 42% to Rs 2,263.80 lakh. Cash from operations: Rs 2,668.23 lakh. The margin before depreciation, interest and tax improved to 9.47% from 6.92% in Q3. Promoter reclassification withdrawn.

Likely market impact

Higher profit, wider operating earnings margin and positive cash flow support shareholders, but slightly lower revenue may limit the upside.

By the numbersStandalone · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹185.2 Cr	₹372.4 Cr	−50.3%
Operating profit	₹14.44 Cr	₹16.51 Cr	−12.5%
Profit after tax	₹11.21 Cr	₹15.91 Cr	−29.5%
EBITDA margin	9.2%	6.0%	+3.2 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.